Esperion Therapeutics | ESPR - Capitalización De Mercado

Precio De Mercado
2.62
Cambio Diario
0.07 2.75%
Mensual
-20.61%
Anual
50.57%
Q1 Expectativa
2.47




Capitalización De Mercado Cambio Fecha
AbbVie USD 403.83B 5.2B 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Alterity Therapeutics Limited AUD 11M 5M 2023-06
Amarin USD 308M 18M 2026-03
Amgen USD 176.25B 24.32B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Cipla INR 1.22T 6.47B 2025-12
CSL USD 71.32B 15.44B 2026-03
Cytokinetics USD 7.77B 1.19B 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Geron USD 843M 31M 2025-12
Grifols EUR 2.02B 4.34B 2026-03
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Merck USD 261.26B 51.62B 2025-12
Pfizer USD 153.96B 12.4B 2026-03
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12